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ABSTRACT
Background In patients who have been mechanically
ventilated, inspiratory muscles remain weak and fatigable
following ventilatory weaning, which may contribute to
dyspnoea and limited functional recovery. Inspiratory
muscle training may improve inspiratory muscle strength
and endurance following weaning, potentially improving
dyspnoea and quality of life in this patient group.
Methods We conducted a randomised trial with
assessor-blinding and intention-to-treat analysis.
Following 48 hours of successful weaning, 70 participants
(mechanically ventilated ≥7 days) were randomised to
receive inspiratory muscle training once daily 5 days/week
for 2 weeks in addition to usual care, or usual care
(control). Primary endpoints were inspiratory muscle
strength and fatigue resistance index (FRI) 2 weeks
following enrolment. Secondary endpoints included
dyspnoea, physical function and quality of life, post-
intensive care length of stay and in-hospital mortality.
Results 34 participants were randomly allocated to the
training group and 36 to control. The training group
demonstrated greater improvements in inspiratory
strength (training: 17%, control: 6%, mean difference:
11%, p=0.02). There were no statistically signiﬁcant
differences in FRI (0.03 vs 0.02, p=0.81), physical
function (0.25 vs 0.25, p=0.97) or dyspnoea (−0.5 vs
0.2, p=0.22). Improvement in quality of life was greater
in the training group (14% vs 2%, mean difference 12%,
p=0.03). In-hospital mortality was higher in the training
group (4 vs 0, 12% vs 0%, p=0.051).
Conclusions Inspiratory muscle training following
successful weaning increases inspiratory muscle strength
and quality of life, but we cannot conﬁdently rule out an
associated increased risk of in-hospital mortality.
Trial registration number ACTRN12610001089022,
results.
INTRODUCTION
Invasive mechanical ventilation causes respiratory
muscle weakness in intensive care unit (ICU)
patients.1 After 18–69 hours of controlled mechan-
ical ventilation, diaphragm proteolysis and atrophy
occur1 and respiratory muscle weakness has been
observed both while patients are mechanically ven-
tilated2 and following successful extubation.3 4
Persistent respiratory muscle weakness may contrib-
ute to the residual dyspnoea,4 impaired physical
function4 5 and poor quality of life6 observed in
ICU survivors.
Inspiratory muscle training (IMT) is a relatively
novel training strategy to improve inspiratory
muscle strength in ICU patients. Threshold-based
IMT is performed using a handheld device, which
provides carefully titrated constant resistance on
inspiration only. A preset threshold level of pressure
is required to open a one-way valve and allow
inspiratory ﬂow, which is important in ensuring
accurate titration of resistance as some other IMT
devices are ﬂow-dependent, which means that the
resistance varies with patient effort. Using a thresh-
old IMT device the level of inspiratory pressure
required to open the valve is increased over time to
provide an ongoing training load as the patient’s
inspiratory muscles become stronger. IMT improves
respiratory muscle strength in patients undergoing
invasive mechanical ventilation7–11 and a recent sys-
tematic review suggested that IMT performed prior
to extubation enhances weaning success, although
it does not appear to reduce rates of reintubation
or likelihood of survival.12
However, participation in threshold-based IMT
while mechanically ventilated requires patients to
be alert and cooperative with training.13 For many
reasons, ICU patients may not be suitable candi-
dates for IMT while ventilator-dependent (eg, due
to sedation or delirium) and may only have sufﬁ-
cient cognitive capacity to participate in training
once weaned from mechanical ventilation.
Although case studies have shown improvements in
inspiratory muscle strength with IMT,14 there have
Key messages
What is the key question?
▸ Does inspiratory muscle training enhance
recovery for patients who have been invasively
ventilated for 7 days or longer?
What is the bottom line?
▸ Two weeks of daily supervised inspiratory
muscle training signiﬁcantly improves
inspiratory muscle strength and health-related
quality of life in patients recently weaned from
invasive ventilation.
Why read on?
▸ Understand how this speciﬁc regime of
inspiratory muscle training may be a useful
adjunct to the medical management of patients
in the postweaning period.
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been no randomised trials of IMT in ICU patients in the postex-
tubation period.
As residual inspiratory muscle impairment has been demon-
strated in intensive care survivors ventilated for 7 days or longer,3 4
we conducted a randomised trial to establish the effects of postex-
tubation IMT in a heterogeneous sample of ICU patients who had
been invasively ventilated for at least 7 days. Primary endpoints
included inspiratory muscle strength and endurance following
2 weeks of training. This 2 week time frame was selected pragmat-
ically, as pilot data indicated that most intensive care survivors
remained inpatients during this 2 week period and would receive
supervised physiotherapy. To date, no studies of IMT in ICU
patients have included patient-centred outcomes or rates of
readmission to ICU. Therefore, secondary endpoints included
health-related quality of life, dyspnoea and functional levels after
2 weeks of training. Post-intensive care length of stay, rate of inten-
sive care readmission and in-hospital mortality were also explored.
We hypothesised that in the IMT group, improvements in inspira-
tory muscle strength and fatigue resistance would lead to reduced
dyspnoea, improved quality of life and physical function, and
lower rates of intensive care readmission and in-hospital mortality
compared with the control group.15
METHODS
Design
We conducted a single-centre randomised trial with concealed
allocation (computer-generated random-number sequence,
managed by off-site administrative staff and obtained via tele-
phone by the chief investigator following enrolment), assessor-
blinding and intention-to-treat (ITT) analysis.15 The study was
approved by the Australian Capital Territory Health Human
Research Ethics Committee and the University of Queensland
Medical Research Ethics Committee, and the published study
protocol15 (trial registration ACTRN12610001089022) com-
plied with the CONSORT guidelines for clinical trials.16
Participants, therapists, centre
All patients invasively mechanically ventilated for 7 days or
longer were screened for eligibility. Patients were deemed eli-
gible if they had been successfully weaned from mechanical ven-
tilation (>48 hours), and within the 7 days following successful
weaning they met the inclusion criteria (aged ≥16 years, able to
provide informed consent, and alert and able to participate in
training with a Riker17 score of 4). Patients were excluded if
they had participated in IMT while mechanically ventilated,
declined to participate, were pregnant, were not alert or able to
participate with training, were experiencing signiﬁcant pain or
distress that interfered with breathing capacity and were deemed
medically unstable or for palliation (ie, death likely in the next
few weeks). Based on a priori power calculations, a total of 70
participants were required to detect a 0.10 change in the
primary outcome measures with a power of 0.80 (inﬂating
group size by 15% to allow for known mortality of 12.8%15).
Although the minimal clinically important difference in
maximum inspiratory pressure (MIP) scores has not been estab-
lished in this patient group, the 0.10 change level was selected
based on previous studies of inspiratory muscle strength and
fatigue resistance in intensive care survivors3 14 to allow com-
parisons to be drawn between studies. All participants provided
informed written consent to participate in the study.
Training was supervised by registered physiotherapists specif-
ically trained in delivering IMT as described in our previously
published protocols.13 15 Therapists could not be blinded to
group allocation. The study was conducted in an Australian
tertiary hospital (Canberra Hospital) where usual intensive care
practice includes minimal sedation and early proactive mobilisa-
tion.18 A second site was also included (Calvary Hospital);
however, no patients were recruited from this site due to failure
to meet eligibility requirements.
Intervention
Participants were randomised to receive either usual care
(control group) or IMT in addition to usual care (IMT group)
for 2 weeks following enrolment. Usual care physiotherapy
included an individually tailored and supervised programme of
interventions, which included any of the following: assisted
mobilisation, secretion clearance treatments including positive
expiratory pressure techniques, deep breathing exercises without
a resistance device and upper and lower limb exercises.
IMT was performed using the threshold IMT inspiratory
muscle trainer (threshold IMT device HS730, Respironics, New
Jersey, USA). This device was used with the mouthpiece, or a ﬂex-
ible connector if required to attach to a tracheostomy (ﬁgure 1).
Where a tracheostomy remained in situ, IMT was always per-
formed with the cuff inﬂated to ensure accurate loading. The
physiotherapist prescribed an intensity of 50% of MIP for the
ﬁrst training set, but then quickly increased this to the highest tol-
erable intensity that allowed the participant to just complete the
sixth breath in a set of six breaths, with ﬁve sets of six breaths
completed each session. Patients were allowed to rest between
sets until they felt ready to commence the next set, which was
typically less than 1 min of resting. The intensity was increased
daily by the physiotherapist across the training period to provide
an adequate training stimulus. This was achieved by manually
increasing the threshold resistance by 1–2 cm H2O until the par-
ticipant could only just open the poppet valve on the sixth breath
in each set. Training commenced on the day of enrolment and
continued once daily (weekdays only) for 2 weeks. A sham
device was not used for comparison as previous studies of IMT
have found that the sham device may provide a training effect in
participants with very low baseline strength.19
Measures
Primary endpoints
Measures of inspiratory muscle performance were recorded on
enrolment and at the end of the intervention period 2 weeks
Figure 1 Inspiratory muscle training via a tracheostomy. Note the
ﬂexible tubing connecting the inspiratory muscle trainer to the closed
suction device.
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later by six speciﬁcally trained research nurses blinded to group
allocation. Inspiratory muscle strength was assessed as MIP, mea-
sured as previously described15 using a portable MicroRPM
Respiratory Pressure meter (CareFusion, San Diego, USA) in
accordance with the protocol described by the American
Thoracic Society and European Respiratory Society.20 This
device has been shown to have excellent reliability in measuring
MIP in non-ventilated participants (intraclass correlation coefﬁ-
cient 0.83–0.90).21 Raw MIP scores were normalised using the
method described by Evans and Whitelaw22 and have been pre-
sented as percentage of predicted values to account for known
variation of MIP with age and gender. Inspiratory muscle
fatigue was measured using the fatigue resistance index (FRI)
technique described by Chang and colleagues,3 based on the
maximum incremental threshold loading test described in the
American Thoracic Society/European Respiratory Society
guidelines.23The prespeciﬁed endpoint was the between-group
difference in change in outcome measures (ie, the change from
enrolment to 2 week follow-up values).
Secondary endpoints
Measures of quality of life, dyspnoea and physical function were
completed on enrolment and 2 weeks later. Quality of life was
measured using the SF-36v2 tool (acute 1 week time frame)
(under license Quality Metric USA) and the EQ-5D-3L tool
(under license EuroQol International). These tools were admi-
nistered by research nurses blinded to group allocation. The
SF-36 tool has demonstrated reliability, responsiveness, con-
struct and criterion validity and is responsive to clinical
improvement in an intensive care population.24 The EQ-5D-3L
tool has also been used in intensive care patient follow-up25 and
is likely to give a more general measure of health-related quality
of life than the SF-36.
Dyspnoea was measured using a Modiﬁed Borg Dyspnoea
scale, where dyspnoea is a patient-reported categorical score out
of 10, which has acceptable reliability and validity in patients
undergoing mechanical ventilation.26 Dyspnoea was recorded
both at rest (sitting comfortably in the chair or bed) and during
exercise (the peak exercise activity experienced in the previous
24 hours) by research nurses blinded to group allocation.
Functional level including mental status, bed mobility, trans-
fers and mobility was assessed using the acute care index of
function (ACIF),27 which has excellent inter-rater reliability in
ICU patients.28 Scores on enrolment were completed by phy-
siotherapists blinded to group allocation; however, follow-up
ACIF scores were recorded by the treating physiotherapist who
was not blinded to group allocation.
Other secondary endpoints included rate of ICU readmission,
requirement for reintubation, post-ICU hospital length of stay
and in-hospital mortality. These data were extracted from hos-
pital databases by research nurses blinded to group allocation.
Post hoc analysis of participants who died during the hospital
admission included retrospective calculation of the risk of death
based on acute physiology and chronic health evaluation
(APACHE II) scores.
Data analysis
The ITT population was deﬁned as all 70 randomised partici-
pants. The per-protocol population was deﬁned as all partici-
pants with both enrolment and 2 week follow-up data. All
analyses were repeated in both the ITTand per-protocol popula-
tions. Paired t-tests were used to compare within-group differ-
ences. Mixed linear models were used to assess the
between-group difference of the changes between enrolment and
follow-up measures, including age and APACHEII scores as cov-
ariates. Diagnostic plots (predicted means vs Pearson’s residuals)
were generated to assess model assumptions. Mortality data were
analysed using χ2 and Fisher’s exact test. Statistical signiﬁcance
was set as p<0.05. All analyses were done using SPSS V.21.
RESULTS
Flow of participants through the study
The ﬂow of participants is presented in ﬁgure 2. Between
February 2011 and August 2015, 70 participants were recruited
to participate in the study with 34 allocated to the IMT group
and 36 to the control group. Participant characteristics are pre-
sented in table 1 and are similar between IMT and control
groups, except for a higher percentage of male participants in
the IMT group (71% vs 58%).
The most frequent reason for exclusion from the study was
poor neurological status with resultant inability to provide
consent. Six participants were lost to follow-up in each group,
most commonly due to transfer to another hospital within the
study period. Two participants died within the intervention
period, both in the IMT group. Two participants died after the
intervention but prior to hospital discharge, both in the IMT
group. Thus, the total mortality in the treatment group was
12%, compared with 0% in the control group. Where patients
were lost to follow-up regarding the primary outcome measures,
other postintervention secondary measures were still obtained
through hospital databases (table 3).
Compliance with trial protocol
In the IMT group, across the 34 participants, 85% of all
intended IMT treatments (potential 10 treatments for each
patient) were completed. Twenty-three participants (67%) com-
pleted more than 90% of the prescribed IMT sessions, while
two (6%) participants completed 20% or less of the prescribed
IMT sessions. The most frequent reason for lack of completion
was participant refusal due to generalised fatigue. IMTwas gen-
erally well tolerated and no adverse effects were reported
during or immediately after training in any participant. No par-
ticipants in the control group inadvertently received IMT. Two
participants (both in the control group) were discharged home
prior to completion of the 2 week intervention period;
however, they attended the outpatient department for comple-
tion of outcome measures.
Effect of intervention
The ITT and per-protocol analyses yielded entirely congruent
results; therefore, only the ITT analysis is presented. Changes in
outcome measures within and between groups are summarised
in online supplementary table E1 and table 2. MIP improved in
both groups, with a statistically signiﬁcant greater increase in the
IMT group than the control group (17% in IMT group vs 6%
in control, p=0.024) (ﬁgure 3A). No statistically signiﬁcant
change in FRI was observed for either group at the end of the
study period (0.03 vs 0.02, p=0.81) (ﬁgure 3B).
Both quality-of-life measures demonstrated statistically signiﬁ-
cant improvements from baseline in the IMT group only (mean
difference=14, p=0.001 for EQ5D; mean difference=0.08,
p=0.001 for SF-36) (ﬁgure 4A, B). Between groups, the differ-
ence in EQ5D scores was higher in the IMT group (14 vs 2,
p=0.034). There was no statistically signiﬁcant difference in
SF-36 scores, although the point estimates suggested a potential
beneﬁt (mean difference=0.05, 95% CI=−0.01 to 0.10).
Both groups demonstrated signiﬁcant improvements in func-
tional outcomes, as measured by the ACIF (ﬁgure 4C); however,
814 Bissett BM, et al. Thorax 2016;71:812–819. doi:10.1136/thoraxjnl-2016-208279
Critical care
group.bmj.com on August 28, 2016 - Published by http://thorax.bmj.com/Downloaded from 
these improvements did not differ between groups (0.25 vs
0.25, p=0.974). Changes in dyspnoea scores both at rest and
during exercise were not statistically signiﬁcant either within or
between groups across the intervention period.
There were no signiﬁcant differences between groups for
post-ICU length of stay, reintubation rate or ICU readmission
(table 3). However, in-hospital mortality was higher in the IMT
group (p=0.051) with four deaths, two during the 2 week inter-
vention period and two following the intervention period (see
online supplementary table E2 for details regarding causes of
death).
DISCUSSION
We have shown for the ﬁrst time that in the postextubation
period, participants who complete 2 weeks of IMT have greater
improvement in respiratory muscle strength than those who do
not train. This is congruent with previous studies of IMT in
mechanically ventilated patients8 10 11 and with the rapid
strength gains within 2 weeks of commencing IMT previously
described in healthy cyclists (eg, increased MIP scores by
8.4%29). It is possible that some of the apparent strength gains
could be attributable to a learning effect, given the similarity
between the IMT technique and the MIP testing manoeuvre.
However, in ICU patients rapid atrophy has been observed in
both skeletal30 and respiratory muscles1 within the ﬁrst few days
of admission. With an adequate training stimulus, some of these
changes could be reversible within a relatively short time frame,
although it appears that some individuals respond to training
more than others (see online supplementary ﬁgure E1).
Regardless of the underlying mechanism of improvement, the
Figure 2 Flow of participants through study. ACIF, acute care index of function; CVA, cerebrovascular accident; FRI, fatigue resistance index; ICU, intensive
care unit; IMT, inspiratory muscle training; MIP, maximum inspiratory pressure; QOL, quality of life; RPE, rate of perceived exertion; TBI, traumatic brain injury.
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apparent strength gains in this cohort translated into beneﬁts in
quality of life, which is arguably a more important patient-
centred outcome than inspiratory muscle strength.
Our inability to demonstrate an improvement in inspiratory
muscle endurance in the IMT group is somewhat surprising, as
IMT has been shown to increase proliferation of both type 1
and type 2 inspiratory muscle ﬁbres31 and endurance beneﬁts of
IMT have been reported after 8 weeks of training in patients
with COPD,32 after 11 weeks of training in athletes33 and after
4 weeks of training in recreationally active people.34 While it is
possible that the speciﬁc training regime employed in our study
translates into strength beneﬁts alone, it is more likely that the
duration of training was insufﬁcient to affect a measurable
improvement in endurance, or that the FRI is insufﬁciently sen-
sitive to detect subtle changes in endurance over such a short
time frame. A more sustained constant loading test may have
better elucidated changes in inspiratory muscle endurance;
however, our experience with these participants resonated with
that of Chang and colleagues3 who found a limited tolerance
for even the basic 2 min FRI test. Thus, measuring inspiratory
muscle endurance in this patient group remains a challenge.
The statistically signiﬁcant improvements in quality of life in
the IMT group, as measured with the EQ5D tool (ﬁgure 4A),
warrant further exploration. The magnitude of change in EQ5D
scores (14 in the IMT group compared with two in the control)
is likely to be clinically important in this group, which struggles
with poor quality of life following weaning. While the IMT
group commenced from a lower baseline EQ5D score (41 in the
IMT group compared with 51 in the control) (see online sup-
plementary table E1) we believe that it is unlikely that there was
a ceiling effect in this cohort, as scores at 2 weeks remained well
below maximal values (ie, mean 54% across both groups). We
would expect quality of life to continue a slow trajectory of
improvement beyond the ICU stay35 but it is possible that IMT
provides an advantage early in this trajectory.
Although the IMT group expressed improved quality of life
using the EQ5D tool, the effect was less marked when assessed
by the SF36. This may reﬂect difﬁculty in completing all compo-
nents of the longer SF36 questionnaire. One of the challenges in
ICU outcomes research is the effect of residual cognitive impair-
ment5 and fatigue on a participant’s ability to complete lengthy
quality-of-life assessment tools. The reasons for improved quality
of life in the absence of a demonstrated effect on respiratory
endurance, dyspnoea or functional level remain unclear.
Improvements in inspiratory muscle strength did not have a
clinically or statistically signiﬁcant impact on the other patient-
centred outcomes in this study. While physical function
improved similarly in both groups, it is likely that other aspects
of treatment (eg, whole body exercise and gait retraining) had a
Table 1 Characteristics of participants
Characteristic
Randomised (n=70)
Lost to follow-up
(n=12)
IMT
(n=34)
Control
(n=36)
IMT
(n=6)
Control
(n=6)
Age (year), mean (SD) 59 (16) 59 (13) 67 (11) 50 (10)
Gender, n males (%) 24 (71) 21 (58) 4 (67) 2 (33)
Diagnosis, n (%)
Sepsis 4 (12) 9 (25) 0 (0) 1 (17)
Pneumonia 4 (12) 7 (19) 0 (0) 0 (0)
Multitrauma 6 (18) 8 (22) 0 (0) 2 (33)
CVA 1 (3) 1 (3) 0 (0) 0 (0)
Respiratory failure 4 (12) 1 (3) 0 (0) 0 (0)
Cardiothoracic surgery 1 (3) 1 (3) 2 (33) 0 (0)
Abdominal surgery 3 (9) 1 (3) 2 (33) 0 (0)
Encephalopathy/
seizures
3 (9) 4 (11) 1 (17) 1 (17)
Other 8 (24) 4 (11) 1 (17) 2 (33)
APACHE II scores, mean
(SD)
20.1 (7.8) 22.9 (8.3) 23.5 (9.0) 19.3 (12.0)
Highest SOFA score,
mean (SD)
7 (4) 8 (4) 4 (2) 7 (5)
Length of ICU stay
(days), mean (SD)
15 (6) 13 (8) 20 (7) 9 (1)
Total duration of
ventilation (days), mean
(SD)
11 (4) 10 (2) 14 (7) 8 (1)
Duration of PSV (days),
mean (SD)
10 (4) 9 (3) 12 (7) 7 (1)
APACHE II, acute physiology and chronic health evaluation score; CVA,
cerebrovascular accident; ICU, intensive care unit; IMT, inspiratory muscle training;
PSV, pressure support ventilation; SOFA, sequential organ failure assessment score.
Table 2 Differences within and between groups for each outcome
measure at 2 weeks
Outcome
Differences within
groups
Differences between
groups (mixed model
analysis)
p Value
Week 2 minus week 0
Mean (SEM)
Difference between
groups (95% CI)
IMT
(n=34)
Control
(n=36)
MIP %
predicted
17 (4) 6 (3) 11 (2 to 20) 0.024*
Fatigue
resistance
index/1.00
0.03 (0.05) 0.02 (0.5) 0.02 (−0.15 to 0.12) 0.816
QOL: SF-36 0.08 (0.02) 0.04 (0.02) 0.05 (−0.01 to 0.10) 0.123
QOL: EQ5D 14 (4) 2 (4) 12 (1 to 23) 0.034*
ACIF/1.00 0.25 (0.04) 0.25 (0.04) 0.00 (−0.12 to 0.12) 0.974
Dyspnoea at
rest/10
−0.8 (0.4) −0.4 (0.4) −0.4 (−1.5 to 0.7) 0.483
Dyspnoea
during
exercise/10
−0.5 (0.4) 0.2 (0.4) −0.7 (−1.8 to 0.4) 0.223
*=p<0.05. **=p<0.01. ***=p<0.001. All analyses are intention-to-treat.
ACIF, acute care index of function; IMT, inspiratory muscle training; MIP, maximum
inspiratory pressure; QOL, quality of life (SF-36 or EQ5D tools).
Table 3 Comparisons between groups for postintervention
outcome measures
Randomised (n=70)
Outcome
IMT
(n=34)
Control
(n=36)
Post-ICU hospital length of stay (days), mean
(SEM)
35 (8) 37 (9)
Number of participants readmitted to ICU, n (%) 6 (18) 8 (22)
Number of participants reintubated, n (%) 6 (18) 8 (22)
In-hospital mortality, n (%) 4 (12)* 0 (0)
*p=0.051 between IMT and control groups.
ICU, intensive care unit; IMT, inspiratory muscle training.
816 Bissett BM, et al. Thorax 2016;71:812–819. doi:10.1136/thoraxjnl-2016-208279
Critical care
group.bmj.com on August 28, 2016 - Published by http://thorax.bmj.com/Downloaded from 
stronger inﬂuence on recovery of physical function than IMT. The
fact that both groups improved in terms of physical function may
reﬂect the high standard of usual care in this unit, which includes
early rehabilitation and mobilisation. Thus, the ﬁndings of this
study may only be generalisable to acute settings where early
mobilisation and rehabilitation are the norm. Furthermore, the
failure of IMT to signiﬁcantly affect reintubation rates or length of
stay may be attributable to the small sample size, as the effect size
of IMT may be very small in relation to the many other variables
that impact on these clinically signiﬁcant outcomes. Future studies
Figure 3 Inspiratory muscle changes in both groups: (A) Changes in
maximum inspiratory pressure scores before and after intervention. (B)
Changes in fatigue resistance index before and after intervention. The
box is drawn from the 25th percentile to the75th percentile, and the
whiskers are drawn at 1.5 times IQR, with outliers represented with
dots. IMT, inspiratory muscle training; MIP, maximum inspiratory
pressure
Figure 4 Quality of life and functional measures in both groups:
(A) Changes in EQ5D scores before and after intervention. (B) Changes
in SF36 scores before and after intervention. (C) Changes in acute care
index of function before and after intervention. The box is drawn from
the 25th percentile to the75th percentile, and the whiskers are drawn
at 1.5 times IQR, with outliers represented with dots. FRI, fatigue
resistance index; IMT, inspiratory muscle training
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of IMT in the postweaning period should be adequately powered
to further clarify these relationships.
The difference in in-hospital mortality between groups was
unexpected, although the mortality in the IMT group (12%)
was close to that anticipated in the trial design (12.8%). To our
knowledge, no increase in mortality has been reported with
IMT in any population to date, including ventilated ICU
patients, or patients with COPD or heart failure. As summarised
in online supplementary table E2, none of the deaths appeared
to be related directly to IMT or respiratory complications.
Given the small number of study participants and heterogeneity
of diagnoses, further study of the impact of IMT on in-hospital
mortality is indicated before robust conclusions about mortality
can be drawn.
Limitations of this study include a loss to follow-up of 17%,
which should have been partly offset by the planned sample size
augmentation of 15% to account for anticipated mortality.
A lack of follow-up of primary outcomes beyond 2 weeks is
another limitation. Moreover, some patients may beneﬁt from
ongoing IMT beyond a 2 week training period, particularly as
most did not return to 100% of predicted MIP values during
this study. In patients with COPD, IMT has longer-term beneﬁts
including lower rates of hospitalisation over a 12 month
period.36 It is possible therefore that IMT in the postextubation
period has ongoing effects, which should be assessed further.
With regard to the training device, a ceiling effect was prob-
lematic in two participants whose MIP exceeded 82 at baseline.
As the maximum resistance setting on the device is 41 cm H2O, it
was impossible to provide training at greater than 50% of MIP in
these two participants. While all other participants commenced
at 50% MIP intensity during the training period, 16 participants
(47%) achieved the 41 cm H2O maximal setting on the device at
some point during the 2 week period, limiting further incremen-
tal training. Thus, our study may have underestimated the poten-
tial impact of IMT. In future studies of IMTwe recommend using
a device with the capacity to provide higher training intensities,
such as an electronic device.37 Furthermore, future studies may
target those with identiﬁable strength deﬁcits, as these may con-
stitute a subgroup, which is most likely to beneﬁt from training,
while those with high baseline values have probably diluted the
potential beneﬁts of training in our cohort.
This study is the ﬁrst to demonstrate the value of IMT for
patients in the postextubation period. IMT can be considered an
effective strategy to reverse some of the residual inspiratory
muscle weakness, which is common following prolonged mech-
anical ventilation, and may enhance quality of life in these
patients with just 2 weeks of training. Future studies of ICU
patients in the postextubation period should further explore the
impact of IMTon quality of life, as well as the longer term effects
of IMT in this group, including effects on mortality.
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